electroCore, Inc. (ECOR) vs Neumora Therapeutics, Inc. Common Stock (NMRA)

A side-by-side comparison of electroCore, Inc. and Neumora Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
electroCore, Inc. logo
ECOR
electroCore, Inc.
$90M
$10.03HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Neumora Therapeutics, Inc. Common Stock logo
NMRA
Neumora Therapeutics, Inc. Common Stock
$90M
$0.48HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT

Total return — ECOR vs NMRA

growth of $100 · dividends reinvested · last 3y
ECOR +80.9% (+21.8%/yr)NMRA -96.8% (-68.1%/yr)ECOR compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100202420252026$181$3
ECOR NMRA

ECOR vs NMRA: by the numbers

  • •ECOR is the larger company ($90M vs $90M market cap).
  • •Both run net losses; NMRA's is the smaller (0.00% vs -39.96% net margin).

Metrics side by side

Valuation

MetricECORNMRA
P/S ratio2.45N/A
P/B ratioN/A2.01

Profitability

MetricECORNMRA
Gross margin87.06%0.00%
Operating margin-37.64%0.00%
Net margin-39.96%0.00%
ROEN/A-477.87%
ROIC-217.73%-216.05%

Growth (annualized)

MetricECORNMRA
Revenue CAGR (5Y)52.51%N/A
Total return CAGR (5Y)-8.10%N/A

Go deeper

Full ECOR analysisFull NMRA analysisInteractive comparison tool

Dig into the metrics

electroCore ROENeumora Therapeutics, Inc. Common Stock ROEelectroCore operating marginNeumora Therapeutics, Inc. Common Stock operating marginelectroCore revenue growthNeumora Therapeutics, Inc. Common Stock revenue growthelectroCore free cash flowNeumora Therapeutics, Inc. Common Stock free cash flow

electroCore & Neumora Therapeutics, Inc. Common Stock appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.